CytoMed Therapeutics (GDTC) Short term Debt (2021 - 2026)
CytoMed Therapeutics (GDTC) recorded Short term Debt of $25,753 in Q2 2023.
Analysis
CytoMed Therapeutics (GDTC) Short term Debt (2021 - 2026) Analysis & Trends
At the end of FY2022, CytoMed Therapeutics reported Short term Debt of $3.4 million, up 47.2% from FY2021.
- Across earlier years, Short term Debt came in at $2.31 million in FY2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | CytoMed Therapeutics | 9.94 Mn | -1.15 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41,845.00 |
| Dec 31, 2025 | 40,847.00 |
| Jun 30, 2023 | 25,753.00 |
| Dec 31, 2022 | 3.40 Mn |
| Dec 31, 2021 | 2.31 Mn |
API Access
CytoMed Therapeutics Short term Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-debt&ticker=GDTC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-debt", "ticker": "GDTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=short-term-debt&ticker=GDTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();